ImageneBio, Inc (IMA)
NGM · Common · CUSIP 45175G207
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for IMA and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
45175G207 (prev. 45175G108 )
Market Cap
Large Cap
IPO
3/26/2021 · $16:00/share
Previous Symbol
IKNA (changed 7/25/2025)
Previous Name
Ikena Oncology, Inc.
Business: ImageneBio is a global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases.

Company Contact

CEO
Kristin Yarema
VPF
Douglas R. Carlson
Headquarters
12526 High Bluff Drive, Suite 345, San Diego, CA 02130
Phone
617-901-7098
Investor Relations
Anna Vardanyan · 646-233-4302 · vardanyana@inmagenebio.com
SEC EDGAR Filings
View filings »